Charles W. Francis
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management 78
- Emergency Medical Services top 0.02%
- Central Venous Catheters and Hemodialysis 21
-
- Atrial Fibrillation Management and Outcomes 25
- Acute Myocardial Infarction Research 19
- Hematology top 0.2%
- Blood Coagulation and Thrombosis Mechanisms 25
- Platelet Disorders and Treatments 17
- Surgery top 0.5%
-
- Blood properties and coagulation 37
-
- Ultrasound and Hyperthermia Applications 18
Charles W. Francis
167 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Internal Medicine 10.0k
- Emergency Medical Services 2.7k
- Cardiology and Cardiovascular Medicine 6.4k
- Hematology 2.9k
- Surgery 3.8k
Countries citing papers authored by Charles W. Francis
This map shows the geographic impact of Charles W. Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Francis more than expected).
Fields of papers citing papers by Charles W. Francis
This network shows the impact of papers produced by Charles W. Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Francis. The network helps show where Charles W. Francis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles W. Francis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Updatebreakdown → | 2019 | 934 |
| 3 | 2019 | 1 | |
| 4 | 2017 | 96 | |
| 5 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014breakdown → | 2015 | 968 |
| 6 | 2015 | 22 | |
| 7 | 2012 | 8 | |
| 8 | 2009 | 76 | |
| 9 | 2007 | 140 | |
| 10 | 2006 | 65 | |
| 11 | 2005 | 13 | |
| 12 | Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty | 2002 | 47 |
| 13 | 2001 | 43 | |
| 14 | 1998 | 196 | |
| 15 | 1997 | 202 | |
| 16 | 1993 | 91 | |
| 17 | 1990 | 29 | |
| 18 | 1990 | 150 | |
| 19 | 1988 | 8 | |
| 20 | 1987 | 6 |
About Charles W. Francis
Charles W. Francis is a scholar working on Internal Medicine, Hematology and Emergency Medical Services, having authored 170 papers that have together received 15.6k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (78 papers), Blood properties and coagulation (37 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers), Atrial Fibrillation Management and Outcomes (25 papers), Central Venous Catheters and Hemodialysis (21 papers), Acute Myocardial Infarction Research (19 papers), Ultrasound and Hyperthermia Applications (18 papers) and Platelet Disorders and Treatments (17 papers). The work is most often cited by research in Internal Medicine (10.0k citations), Emergency Medical Services (2.7k citations) and Cardiology and Cardiovascular Medicine (6.4k citations). Charles W. Francis has collaborated with scholars based in United States, Canada and Iceland. Frequent co-authors include Alok A. Khorana, Gary H. Lyman, Nicole M. Kuderer, Eva Culakova, Abha Sahni, Victor J. Marder, Thomas L. Ortel, Clifford W. Colwell, Anna Falanga and Mark N. Levine. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.